Why customers are switching to Medidata CTMS and eTMF
Industry-Leading Clinical Trial Management Technology*
Medidata CTMS leads the CTMS market ahead of thirteen CTMS products evaluated in Everest Group’s Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix® Assessment 2024.
Future Proofed Trials, Powered by AI
With a decade of AI expertise and models trained on data from over 36,000 clinical trials, Medidata delivers the industry’s most advanced AI, transforming trial execution.
Fastest Time to Value
The Medidata Professional Service team is a true partner delivering comprehensive enablement beyond the implementation of CTMS and eTMF, maximizing the system’s value.
Medidata has a long history of delivering over 400 successful CTMS and eTMF implementations, leveraging industry-savvy in-house experts and advanced implementation accelerator technology. Over 50% of Medidata CTMS customers have been with Medidata for more than five years.
Catalyst Clinical Research is a full-service CRO focusing exclusively on oncology, primarily in early development. Catalyst has been an early adopter of Medidata’s complete platform of unified applications for end-to-end trial management.
“In Medidata, we found a CTMS system and partner that can grow with us. We’ve future-proofed our business and are thrilled with our decision.”
Enterin is pioneering the medical community’s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease.
“By automating manual workflows and bringing all of our data together, Medidata CTMS has streamlined our entire clinical trial management lifecycle.”
Alnylam is developing RNAi-based medicines that will benefit as many patients as possible. Alnylam has pioneered RNA interference (RNAi) therapeutics, an innovative class of medications that treat diseases differently by silencing the genes that cause or contribute to them.
“We appreciate that Medidata CTMS is built on a single platform. It enables us to consolidate data from various sources into one location, ensuring a unified source of truth and a consistent system of record.”
Westat offers large and small-scale surveys, program assessments and evaluations, capacity building and training, clinical trials management and operations, epidemiological studies, and communication and dissemination strategies.
“Medidata CTMS is intuitive and allows for much smoother work for our CRAs across our worldwide studies. It’s almost like our CRAs have done a full 180.”
QuidelOrtho is at the forefront of testing, tracking, and disease analysis for health conditions ranging from HIV and hepatitis C to flu, strep, and COVID-19. Its diagnostic products and services have guided clinicians and lab technicians in the moments that matter most for decades.
“We are excited about where Medidata is going with CTMS.”
Impact Biotech is focused on developing and launching Padeliporfin VTP Therapy, a targeted treatment for the selective ablation of tumors.
“Transitioning an ongoing trial eTMF with over 7,000 regulated content items from an external legacy system and developing new in-house capabilities seemed almost impossible until the Medidata Professional Services team joined our journey. Their expertise in managing the project and upskilling our team ensured a seamless transition, and their dedication to addressing our specific needs made the process highly efficient.”
TRiNDS is a specialized contract research organization (CRO) that conducts high-quality clinical trials in neuromuscular and rare diseases.
“We have been working with Medidata since 2019 because of their superior Medidata eTMF solution and outstanding professional services, training, and post-go-live support. We highly recommend Medidata if you are evaluating eTMF solutions and related services.”
Medidata leverages the best
operational clinical trial dataset:
35K+
Studies
8K+
Active Studies
10M+
Patients
145+
Countries
1M+
Study Sites
2300+
Customers
Industry-Leading CTMS and eTMF Solution
Medidata CTMS and eTMF are built on the industry’s most comprehensive, unified platform, which spans clinical trial processes from planning to execution. With single sign-on and master data management across all capabilities, seamless data flow between Rave EDC, Medidata CTMS, and Medidata eTMF is standard, eliminating the need for integrations. Open APIs ensure compatibility with your existing technology infrastructure, offering flexibility and ease of integration.
Current Medidata CTMS & eTMF Footprint
Medidata is the only vendor that can leverage deep data science expertise and analytics backed by over 36,000 trials to transform trial management within an unparalleled user experience.